PCSK9 Prosegment Chimera as Novel Inhibitors of LDLR Degradation
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference33 articles.
1. The biology and therapeutic targeting of the proprotein convertases;NG Seidah;Nat Rev Drug Discov,2012
2. Insights from bacterial subtilases into the mechanisms of intramolecular chaperone-mediated activation of furin;U Shinde;Methods Mol Biol,2011
3. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;NG Seidah;Proc Natl Acad Sci U S A,2003
4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;M Abifadel;Nat Genet,2003
5. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia;D Cunningham;Nat Struct Mol Biol,2007
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol;Heart Failure Reviews;2024-06-18
2. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside;Signal Transduction and Targeted Therapy;2024-01-08
3. Reframing prosegment‐dependent folding and limits on natural protein folding landscapes from an evolutionary perspective;Proteins: Structure, Function, and Bioinformatics;2023-04-04
4. The Multifaceted Biology of PCSK9;Endocrine Reviews;2021-10-09
5. The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer;Journal of Lipid Research;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3